376 related articles for article (PubMed ID: 32709019)
1. CD38: T Cell Immuno-Metabolic Modulator.
Kar A; Mehrotra S; Chatterjee S
Cells; 2020 Jul; 9(7):. PubMed ID: 32709019
[TBL] [Abstract][Full Text] [Related]
2. Regulation of intracellular levels of NAD: a novel role for CD38.
Aksoy P; White TA; Thompson M; Chini EN
Biochem Biophys Res Commun; 2006 Jul; 345(4):1386-92. PubMed ID: 16730329
[TBL] [Abstract][Full Text] [Related]
3. CD38 as a regulator of cellular NAD: a novel potential pharmacological target for metabolic conditions.
Chini EN
Curr Pharm Des; 2009; 15(1):57-63. PubMed ID: 19149603
[TBL] [Abstract][Full Text] [Related]
4. Enzyme properties of Aplysia ADP-ribosyl cyclase: comparison with NAD glycohydrolase of CD38 antigen.
Inageda K; Takahashi K; Tokita K; Nishina H; Kanaho Y; Kukimoto I; Kontani K; Hoshino S; Katada T
J Biochem; 1995 Jan; 117(1):125-31. PubMed ID: 7775378
[TBL] [Abstract][Full Text] [Related]
5. Kinetic competence of the cADP-ribose-CD38 complex as an intermediate in the CD38/NAD+ glycohydrolase-catalysed reactions: implication for CD38 signalling.
Cakir-Kiefer C; Muller-Steffner H; Oppenheimer N; Schuber F
Biochem J; 2001 Sep; 358(Pt 2):399-406. PubMed ID: 11513738
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of cyclizing NAD to cyclic ADP-ribose by ADP-ribosyl cyclase and CD38.
Graeff R; Liu Q; Kriksunov IA; Kotaka M; Oppenheimer N; Hao Q; Lee HC
J Biol Chem; 2009 Oct; 284(40):27629-36. PubMed ID: 19640843
[TBL] [Abstract][Full Text] [Related]
7. CD38 controls ADP-ribosyltransferase-2-catalyzed ADP-ribosylation of T cell surface proteins.
Krebs C; Adriouch S; Braasch F; Koestner W; Leiter EH; Seman M; Lund FE; Oppenheimer N; Haag F; Koch-Nolte F
J Immunol; 2005 Mar; 174(6):3298-305. PubMed ID: 15749861
[TBL] [Abstract][Full Text] [Related]
8. The CD38 glycohydrolase and the NAD sink: implications for pathological conditions.
Zeidler JD; Hogan KA; Agorrody G; Peclat TR; Kashyap S; Kanamori KS; Gomez LS; Mazdeh DZ; Warner GM; Thompson KL; Chini CCS; Chini EN
Am J Physiol Cell Physiol; 2022 Mar; 322(3):C521-C545. PubMed ID: 35138178
[TBL] [Abstract][Full Text] [Related]
9. Ectocellular CD38-catalyzed synthesis and intracellular Ca2+-signalling activity of cyclic ADP-ribose in T-lymphocytes are not functionally related.
da Silva CP; Schweitzer K; Heyer P; Malavasi F; Mayr GW; Guse AH
FEBS Lett; 1998 Nov; 439(3):291-6. PubMed ID: 9845340
[TBL] [Abstract][Full Text] [Related]
10. CD38: An important regulator of T cell function.
Li W; Liang L; Liao Q; Li Y; Zhou Y
Biomed Pharmacother; 2022 Sep; 153():113395. PubMed ID: 35834988
[TBL] [Abstract][Full Text] [Related]
11. Ligand-induced internalization of CD38 results in intracellular Ca2+ mobilization: role of NAD+ transport across cell membranes.
Zocchi E; Usai C; Guida L; Franco L; Bruzzone S; Passalacqua M; De Flora A
FASEB J; 1999 Feb; 13(2):273-83. PubMed ID: 9973315
[TBL] [Abstract][Full Text] [Related]
12. Structural basis for enzymatic evolution from a dedicated ADP-ribosyl cyclase to a multifunctional NAD hydrolase.
Liu Q; Graeff R; Kriksunov IA; Jiang H; Zhang B; Oppenheimer N; Lin H; Potter BV; Lee HC; Hao Q
J Biol Chem; 2009 Oct; 284(40):27637-45. PubMed ID: 19640846
[TBL] [Abstract][Full Text] [Related]
13. The Multi-faceted Ecto-enzyme CD38: Roles in Immunomodulation, Cancer, Aging, and Metabolic Diseases.
Hogan KA; Chini CCS; Chini EN
Front Immunol; 2019; 10():1187. PubMed ID: 31214171
[TBL] [Abstract][Full Text] [Related]
14. CD38: an ecto-enzyme with functional diversity in T cells.
Ghosh A; Khanam A; Ray K; Mathur P; Subramanian A; Poonia B; Kottilil S
Front Immunol; 2023; 14():1146791. PubMed ID: 37180151
[TBL] [Abstract][Full Text] [Related]
15. Role of CD38 in Adipose Tissue: Tuning Coenzyme Availability?
Benzi A; Grozio A; Spinelli S; Sturla L; Guse AH; De Flora A; Zocchi E; Heeren J; Bruzzone S
Nutrients; 2021 Oct; 13(11):. PubMed ID: 34835990
[TBL] [Abstract][Full Text] [Related]
16. TNB-738, a biparatopic antibody, boosts intracellular NAD+ by inhibiting CD38 ecto-enzyme activity.
Ugamraj HS; Dang K; Ouisse LH; Buelow B; Chini EN; Castello G; Allison J; Clarke SC; Davison LM; Buelow R; Deng R; Iyer S; Schellenberger U; Manika SN; Bijpuria S; Musnier A; Poupon A; Cuturi MC; van Schooten W; Dalvi P
MAbs; 2022; 14(1):2095949. PubMed ID: 35867844
[TBL] [Abstract][Full Text] [Related]
17. Enzymatic synthesis and characterizations of cyclic GDP-ribose. A procedure for distinguishing enzymes with ADP-ribosyl cyclase activity.
Graeff RM; Walseth TF; Fryxell K; Branton WD; Lee HC
J Biol Chem; 1994 Dec; 269(48):30260-7. PubMed ID: 7982936
[TBL] [Abstract][Full Text] [Related]
18. The Pharmacology of CD38/NADase: An Emerging Target in Cancer and Diseases of Aging.
Chini EN; Chini CCS; Espindola Netto JM; de Oliveira GC; van Schooten W
Trends Pharmacol Sci; 2018 Apr; 39(4):424-436. PubMed ID: 29482842
[TBL] [Abstract][Full Text] [Related]
19. Coordinated regulation in human T cells of nucleotide-hydrolyzing ecto-enzymatic activities, including CD38 and PC-1. Possible role in the recycling of nicotinamide adenine dinucleotide metabolites.
Deterre P; Gelman L; Gary-Gouy H; Arrieumerlou C; Berthelier V; Tixier JM; Ktorza S; Goding J; Schmitt C; Bismuth G
J Immunol; 1996 Aug; 157(4):1381-8. PubMed ID: 8759717
[TBL] [Abstract][Full Text] [Related]
20. Paracrine roles of NAD+ and cyclic ADP-ribose in increasing intracellular calcium and enhancing cell proliferation of 3T3 fibroblasts.
Franco L; Zocchi E; Usai C; Guida L; Bruzzone S; Costa A; De Flora A
J Biol Chem; 2001 Jun; 276(24):21642-8. PubMed ID: 11274199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
